These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 9593972)
1. Local injection of alkylating and nonalkylating dopamine receptor antagonists into rat basal forebrain: autoradiographic assessment of D2-like and D3 sites. Yeghiayan SK; Gongwer MA; Baldessarini RJ; Kula NS; Zong R; Neumeyer JL Brain Res; 1998 May; 792(2):324-6. PubMed ID: 9593972 [TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Levant B Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat. Barik S; de Beaurepaire R Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):718-26. PubMed ID: 15913875 [TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride. Booze RM; Wallace DR Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors. Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485 [TBL] [Abstract][Full Text] [Related]
6. Dopamine autoreceptor reserve in vitro: possible role of dopamine D3 receptors. Aretha CW; Galloway MP Eur J Pharmacol; 1996 Jun; 305(1-3):119-22. PubMed ID: 8813541 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of dopamine D3 receptors in the islands of Calleja of the rat using quantitative receptor autoradiography. Hillefors-Berglund M; Von Euler G Eur J Pharmacol; 1994 Aug; 261(1-2):179-83. PubMed ID: 8001642 [TBL] [Abstract][Full Text] [Related]
9. Effects of alkylating agents on dopamine D(3) receptors in rat brain: selective protection by dopamine. Zhang K; Weiss NT; Tarazi FI; Kula NS; Baldessarini RJ Brain Res; 1999 Nov; 847(1):32-7. PubMed ID: 10564733 [TBL] [Abstract][Full Text] [Related]
10. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect? Boulay D; Depoortere R; Perrault G; Sanger DJ Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens. Roberts C; Cummins R; Gnoffo Z; Kew JN Eur J Pharmacol; 2006 Mar; 534(1-3):108-14. PubMed ID: 16490190 [TBL] [Abstract][Full Text] [Related]
12. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved? Maj J; Rogóz Z; Skuza G J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103 [TBL] [Abstract][Full Text] [Related]
14. Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain. Kling-Petersen T; Ljung E; Svensson K J Neural Transm Gen Sect; 1995; 102(3):209-20. PubMed ID: 8788069 [TBL] [Abstract][Full Text] [Related]
15. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181 [TBL] [Abstract][Full Text] [Related]
16. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study. Amenta F; Bronzetti E; Felici L; Ricci A; Tayebati SK J Auton Pharmacol; 1999 Jun; 19(3):151-9. PubMed ID: 10511471 [TBL] [Abstract][Full Text] [Related]
18. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis. Rogoz R; Dziedzicka-Wasylewska M Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):178-86. PubMed ID: 10208304 [TBL] [Abstract][Full Text] [Related]
19. Functional and autoradiographic characterization of dopamine D2-like receptors in the guinea pig heart. Gómez Mde J; Rousseau G; Nadeau R; Berra R; Flores G; Suárez J Can J Physiol Pharmacol; 2002 Jun; 80(6):578-87. PubMed ID: 12117307 [TBL] [Abstract][Full Text] [Related]
20. The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum. Gilbert DB; Millar J; Cooper SJ Brain Res; 1995 May; 681(1-2):1-7. PubMed ID: 7552265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]